Aflac Cancer and Blood Disorders program receives $20 million for pediatric cancer trials

After 51 years, Montefiore Einstein Cancer Center earns the Comprehensive designation

Montefiore Einstein Cancer Center can now add the word “Comprehensive” to its logo.

September 15, 2023

Obstacles cleared for Bertagnolli’s confirmation as NIH director
Senate HELP Committee schedules hearing

A confirmation hearing for NCI Director Monica Bertagnolli will take place sometime in October, said Sen. Bernie Sanders (I-VT), chairman of the Senate Health, Education, Labor, and Pensions Committee.

September 15, 2023

Vol.49 No.34

By Matthew Bin Han Ong

IU Simon’s healthy breast tissue biobank now seeks to understand how breast cancer develops—in men

The world’s only biobank that collects healthy breast tissue is once again taking the lead to fulfill another unmet need in breast cancer research: collecting tissue from men to understand how male breast cancer develops.

September 15, 2023

Vol.49 No.34

By Matthew Bin Han Ong

Guest Editorial

The insinuation that AstroTurf causes GBM has no basis in science
The Philadelphia Inquirer series does disservice to brain tumor community

We see far too many patients with glioblastoma (GBM), an aggressive and almost always fatal malignant brain tumor.

September 15, 2023

Vol.49 No.34

By Henry S. Friedman and Kyle M. Walsh

Obituary

David Alberts, founding member of the University of Arizona Cancer Center, dies at 83

As a founding member of the University of Arizona Cancer Center, David Alberts, MD, and his influence on cancer research epitomizes Isaac Newton’s famous quote, “If I have seen further, it is by standing on the shoulders of giants.”

September 15, 2023

Vol.49 No.34

By Lisa M. Dahm and Mark Anthony Febbo

In the Archives

In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch

At 75, Chris Lundy is one of the longest living recipients of a bone marrow transplant.

September 15, 2023

Vol.49 No.34

By Deborah Doroshow and Alexandria Carolan

Aflac Cancer and Blood Disorders program receives $20 million for pediatric cancer trials

YOU MAY BE INTERESTED IN

After 51 years, Montefiore Einstein Cancer Center earns the Comprehensive designation

Obstacles cleared for Bertagnolli’s confirmation as NIH director
Senate HELP Committee schedules hearing

IU Simon’s healthy breast tissue biobank now seeks to understand how breast cancer develops—in men

The insinuation that AstroTurf causes GBM has no basis in science
The Philadelphia Inquirer series does disservice to brain tumor community

David Alberts, founding member of the University of Arizona Cancer Center, dies at 83

In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch

Renew today!

Subscriber content

Login

Aflac Cancer and Blood Disorders program receives $20 million for pediatric cancer trials

YOU MAY BE INTERESTED IN

After 51 years, Montefiore Einstein Cancer Center earns the Comprehensive designation

Obstacles cleared for Bertagnolli’s confirmation as NIH directorSenate HELP Committee schedules hearing

IU Simon’s healthy breast tissue biobank now seeks to understand how breast cancer develops—in men

The insinuation that AstroTurf causes GBM has no basis in scienceThe Philadelphia Inquirer series does disservice to brain tumor community

David Alberts, founding member of the University of Arizona Cancer Center, dies at 83

In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch

Login

Obstacles cleared for Bertagnolli’s confirmation as NIH director
Senate HELP Committee schedules hearing

The insinuation that AstroTurf causes GBM has no basis in science
The Philadelphia Inquirer series does disservice to brain tumor community